Detalles de la búsqueda
1.
Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States.
Clin Infect Dis
; 76(3): e460-e468, 2023 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35580849
2.
mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients.
J Infect Dis
; 226(5): 797-807, 2022 09 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35385875
3.
Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021.
J Infect Dis
; 225(10): 1694-1700, 2022 05 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34932114
4.
Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States.
Clin Infect Dis
; 74(9): 1515-1524, 2022 05 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34358310
5.
Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States.
Clin Infect Dis
; 75(Suppl 2): S159-S166, 2022 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35675695
6.
Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022.
MMWR Morb Mortal Wkly Rep
; 71(42): 1327-1334, 2022 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36264830
7.
Effectiveness of mRNA Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death - United States, March 2021-January 2022.
MMWR Morb Mortal Wkly Rep
; 71(12): 459-465, 2022 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35324878
8.
Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021.
MMWR Morb Mortal Wkly Rep
; 71(4): 118-124, 2022 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35085218
9.
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021.
MMWR Morb Mortal Wkly Rep
; 70(18): 674-679, 2021 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33956782
10.
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.
MMWR Morb Mortal Wkly Rep
; 70(38): 1337-1343, 2021 Sep 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34555004
11.
Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021.
MMWR Morb Mortal Wkly Rep
; 70(34): 1156-1162, 2021 Aug 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34437524
12.
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.
JAMA
; 326(20): 2043-2054, 2021 11 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34734975
13.
Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States.
Vaccine
; 40(48): 6979-6986, 2022 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36374708
14.
Clinical Severity and mRNA Vaccine Effectiveness for Omicron, Delta, and Alpha SARS-CoV-2 Variants in the United States: A Prospective Observational Study.
medRxiv
; 2022 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35169811
15.
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study.
BMJ
; 376: e069761, 2022 03 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35264324
16.
Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States.
medRxiv
; 2021 Jul 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34268515
Resultados
1 -
16
de 16
1
Próxima >
>>